Literature DB >> 1610789

Molecular characterization of two galactosemia mutations and one polymorphism: implications for structure-function analysis of human galactose-1-phosphate uridyltransferase.

J K Reichardt1, H L Levy, S L Woo.   

Abstract

We report here the molecular characterization of two galactosemia mutations, L74P and F171S, and one polymorphism, S135L, in human galactose-1-phosphate uridyltransferase (GALT). Both galactosemia mutations result in reduced enzymatic activity when reconstructed in the cDNA and overexpressed. The polymorphism, in contrast, has near normal activity. Both mutations affect evolutionarily conserved residues, suggesting that they are functionally important, while the polymorphism occurs in a nonconserved domain which is presumably not critical for enzymatic function. The F171S mutation is close to the putative active-site nucleophile. Our data further support the notion of molecular heterogeneity of galactosemia and suggest that galactosemia mutations and GALT polymorphisms may be useful tools in highlighting different functional domains in human GALT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610789     DOI: 10.1021/bi00139a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia.

Authors:  L Wells; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.

Authors:  Ying Liu; Baoyun Xia; Tyler J Gleason; Uriel Castañeda; Miao He; Gerard T Berry; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2012-06-12       Impact factor: 4.797

3.  Three missense mutations in the galactose-1-phosphate uridyltransferase gene of three families with mild galactosaemia.

Authors:  Y S Shin; B S Gathof; T Podskarbi; M Sommer; R Giugliani; U Gresser
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

4.  The molecular basis of transferase galactosaemia in South African negroids.

Authors:  N Manga; T Jenkins; H Jackson; D A Whittaker; A B Lane
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

5.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

6.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

7.  Characterization of two stop codon mutations in the galactose-1-phosphate uridyltransferase gene of three male galactosemic patients with severe clinical manifestation.

Authors:  B S Gathof; M Sommer; T Podskarbi; J Reichardt; A Braun; U Gresser; Y S Shin
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

8.  Biochemical and molecular studies of 132 patients with galactosemia.

Authors:  W G Ng; Y K Xu; F R Kaufman; G N Donnell; J Wolff; R J Allen; S Koritala; J K Reichardt
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

9.  Mutations in the galactose-1-phosphate uridyltransferase gene of two families with mild galactosaemia variants.

Authors:  M Sommer; B S Gathof; T Podskarbi; R Giugliani; B Kleinlein; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

10.  A yeast expression system for human galactose-1-phosphate uridylyltransferase.

Authors:  J L Fridovich-Keil; S Jinks-Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.